On Apr. 20, 2020, Alexion announced plans to initiate a global Phase 3 study to investigate ULTOMIRISﾮ (ravulizumab-cwvz)…
On Apr. 20, 2020, Innovation Pharma reported that based on molecular screening of 11,552 compounds comprising already FDA-approved…
On Apr. 20, 2020, IDEXX Labs announced the availability of the IDEXX SARS-CoV-2 (COVID-19) RealPCR Test for pets….
On Apr. 20, 2020, VGX signed as the first occupant of Conroeﾒs Deison Technology Park and will move…
On Apr. 20, 2020, the Rice University COVID-19 Research Fund Oversight and Review Committee announced it will support…
On Apr. 20, 2020, Atossa Therapeutics announced that it had applied to the FDA for approval to commence…
On Apr. 17, 2020, the NIH and the Foundation for the NIH are bringing together more than a…
On Apr. 17, 2020, the NIH announced that early treatment with the experimental antiviral drug remdesivir significantly reduced…
On Apr. 17, 2020, as part of Project Orbis, the U.S. Food and Drug Administration (FDA) approved Seagen’s…
On Apr. 17, 2020, five projects from across Oxford University’s Medical Sciences Division were among twenty-one new studies…
On Apr. 17, 2020, Roche announced the development and upcoming launch of its Elecsys Anti-SARS-CoV-2 serology test to…
On Apr. 17, 2020, Kaiser Permanente Washington Health Research Institute (KPWHRI) announced that older adults were being enrolled…
On Apr. 17, 2020, Sinovac Biotech announced that the Company had commenced Phase I clinical trial, a randomized,…
On Apr. 17, 2020, after promising COVID-19 treatments in Germany, France, Italy, Spain and the U.S,, ExThera Medical’s…
On Apr. 17, 2020, Incyte announced the initiation of RUXCOVID, a global, randomized, double-blind, placebo-controlled phase 3 clinical…
On Apr. 17, 2020, Emory University announced it had begun enrolling adults over age 55 in the clinical…
On Apr. 17, 2020, Celdara Medical announced that it had entered into a Cooperative Research and Development Agreement…
On Apr. 17, 2020, researchers at Montefiore Health System and Albert Einstein College of Medicine may have solved…
On Apr. 17, 2020, the NIH announced nearly $290 million of new funding for seven years to research…
On Apr. 17, 2020, the University of Washington Medicine announced that a new clinical blood test will be…
On Apr. 16, 2020, the International Vaccine Institute (IVI) announced that the Coalition for Epidemic Preparedness Innovations (CEPI)…
On Apr. 16, 2020, Mammoth Biosciences announced the publication of a study demonstrating the power of its platform…
On Apr. 16, 2020, Dynavax and Sinovac Biotech, a leading provider of biopharmaceutical products in China, announced a…
On Apr. 16, 2020, Scripps Research announced that researchers at Calibr, Scripp’s drug development division, had established an…
On Apr. 16, 2020, BioSig Technologies announced that its subsidiary ViralClear Pharmaceuticals, had updated its clinical development program…
On Apr. 16, 2020, Biogen, Broad Institute of MIT and Harvard, and Partners HealthCare announced a consortium that…
On Apr. 16, 2020, Pulmatrix announced a collaboration and license agreement with Sensory Cloud. Under the terms of…
On Apr. 16, 2020, Moderna announced an agreement for a commitment of up to $483 million from the…
On Apr. 16, 2020, a team of researchers at the McGovern Institute for Brain Research at MIT, the…
On Apr. 16, 2020, OpGen announced that a study on the feasibility and potential of antibiotic susceptibility testing…